Overview

Zogenix, Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies targeting rare diseases. It is a subsidiary of UCB, a global biopharmaceutical company specializing in neurology and immunology.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Zogenix, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.